Literature DB >> 31630209

ZBP1 governs the inflammasome-independent IL-1α and neutrophil inflammation that play a dual role in anti-influenza virus immunity.

Masatoshi Momota1,2,3, Patrick Lelliott4, Atsuko Kubo1, Takato Kusakabe1,2,3, Kouji Kobiyama1,5,6, Etsushi Kuroda1,3,7, Yumiko Imai8, Shizuo Akira9, Cevayir Coban4,6,10, Ken J Ishii1,2,3,5,6.   

Abstract

Influenza A virus (IAV) triggers the infected lung to produce IL-1 and recruit neutrophils. Unlike IL-1β, however, little is known about IL-1α in terms of its mechanism of induction, action and physiological relevance to the host immunity against IAV infection. In particular, whether Z-DNA-binding protein 1 (ZBP1), a key molecule for IAV-induced cell death, is involved in the IL-1α induction, neutrophil infiltration and the physiological outcome has not been elucidated. Here, we show in a murine model that the IAV-induced IL-1α is mediated solely by ZBP1, in an NLRP3-inflammasome-independent manner, and is required for the optimal IL-1β production followed by the formation of neutrophil extracellular traps (NETs). During IAV infection, ZBP1 displays a dual role in anti-IAV immune responses mediated by neutrophils, resulting in either protective or pathological outcomes in vivo. Thus, ZBP1-mediated IL-1α production is the key initial step of IAV-infected NETs, regulating the duality of the consequent lung inflammation.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Japanese Society for Immunology.

Entities:  

Keywords:  IL-1; ZBP1; influenza virus; innate immunity; neutrophil

Year:  2020        PMID: 31630209     DOI: 10.1093/intimm/dxz070

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  Benefits and Perils of Necroptosis in Influenza Virus Infection.

Authors:  Siddharth Balachandran; Glenn F Rall
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

Review 2.  Emerging Role of ZBP1 in Z-RNA Sensing, Influenza Virus-Induced Cell Death, and Pulmonary Inflammation.

Authors:  Sharath Basavaraju; Sanchita Mishra; Rashi Jindal; Sannula Kesavardhana
Journal:  mBio       Date:  2022-05-19       Impact factor: 7.786

Review 3.  Role of Selenium and Vitamins E and B9 in the Alleviation of Bovine Mastitis during the Periparturient Period.

Authors:  Muhammad Zahoor Khan; Yulin Ma; Jianxin Xiao; Tianyu Chen; Jiaying Ma; Shuai Liu; Yajing Wang; Adnan Khan; Gibson Maswayi Alugongo; Zhijun Cao
Journal:  Antioxidants (Basel)       Date:  2022-03-29

4.  Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL.

Authors:  Teodora Oltean; Emily Van San; Tatyana Divert; Tom Vanden Berghe; Xavier Saelens; Jonathan Maelfait; Nozomi Takahashi; Peter Vandenabeele
Journal:  Cell Death Dis       Date:  2021-05-11       Impact factor: 8.469

5.  S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.

Authors:  Takayuki Nakagawa; Tetsuya Tanino; Motoyasu Onishi; Soichi Tofukuji; Takayuki Kanazawa; Yukichi Ishioka; Takeshi Itoh; Akira Kugimiya; Kazufumi Katayama; Takuya Yamamoto; Morio Nagira; Ken J Ishii
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

6.  AP-1 signaling pathway promotes pro-IL-1β transcription to facilitate NLRP3 inflammasome activation upon influenza A virus infection.

Authors:  Pin Wan; Simeng Zhang; Zhihui Ruan; Xueli Liu; Ge Yang; Yaling Jia; Yongkui Li; Pan Pan; Wenbiao Wang; Geng Li; Xulin Chen; Zhixin Liu; Qiwei Zhang; Zhen Luo; Jianguo Wu
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

7.  Z-DNA binding protein 1 mediates necroptotic and apoptotic cell death pathways in murine astrocytes following herpes simplex virus-1 infection.

Authors:  Austin M Jeffries; Alexander J Suptela; Ian Marriott
Journal:  J Neuroinflammation       Date:  2022-05-13       Impact factor: 9.587

8.  Interleukin-1β exacerbates disease and is a potential therapeutic target to reduce pulmonary inflammation during severe influenza A virus infection.

Authors:  Abdulah Os Bawazeer; Sarah Rosli; Christopher M Harpur; Callum Ah Docherty; Ashley Mansell; Michelle D Tate
Journal:  Immunol Cell Biol       Date:  2021-05-20       Impact factor: 5.126

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.